Evaluating disease severity by the Quantitative Myasthenia Gravis (QMG) score22,23, the CD180 negative B cells correlated with disease severity (R2 = 0.30, P = 0.025) in MG patients (Fig. 3g). The gene discussed is CD180; the disease is myasthenia gravis.